Evidence map›Paper›PMID 28699224›Full record

ArticleAdvanced healthcare materials2017

Melt Electrospinning Writing of Poly-Hydroxymethylglycolide-co-ε-Caprolactone-Based Scaffolds for Cardiac Tissue Engineering.

Miguel Castilho, Dries Feyen, María Flandes-Iparraguirre, Gernot Hochleitner, Jürgen Groll, Pieter A F Doevendans, Tina Vermonden, Keita Ito, Joost P G Sluijter, Jos Malda

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury.JACC. Basic to translational science · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miguel CastilhoDepartment of Orthopaedics, University Medical Center Utrecht, P.O. Box 85500, Utrecht, GA, 3508, The Netherlands.
Dries FeyenRegenerative Medicine Center Utrecht, Uppsalalaan 8, Utrecht, CT, 3584, The Netherlands.
María Flandes-IparraguirreDepartment of Orthopaedics, University Medical Center Utrecht, P.O. Box 85500, Utrecht, GA, 3508, The Netherlands.
Gernot HochleitnerDepartment of Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, University of Würzburg, Pleicherwall 2, Würzburg, 97070, Germany.
Jürgen GrollDepartment of Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, University of Würzburg, Pleicherwall 2, Würzburg, 97070, Germany.
Pieter A F DoevendansDepartment of Cardiology, Experimental Cardiology Laboratory, University Medical Center Utrecht, P.O. Box 85500, Utrecht, GA, 3508, The Netherlands.
Tina VermondenDepartment of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P. O. Box 80082, Utrecht, TB, 3508, The Netherlands.
Keita ItoDepartment of Orthopaedics, University Medical Center Utrecht, P.O. Box 85500, Utrecht, GA, 3508, The Netherlands.
Joost P G SluijterRegenerative Medicine Center Utrecht, Uppsalalaan 8, Utrecht, CT, 3584, The Netherlands.
Jos MaldaDepartment of Orthopaedics, University Medical Center Utrecht, P.O. Box 85500, Utrecht, GA, 3508, The Netherlands.

Funding

European Research Council 647426
6 · The paper itself

Abstract

Current limitations in cardiac tissue engineering revolve around the inability to fully recapitulate the structural organization and mechanical environment of native cardiac tissue. This study aims at developing organized ultrafine fiber scaffolds with improved biocompatibility and architecture in comparison to the traditional fiber scaffolds obtained by solution electrospinning. This is achieved by combining the additive manufacturing of a hydroxyl-functionalized polyester, (poly(hydroxymethylglycolide-co-ε-caprolactone) (pHMGCL), with melt electrospinning writing (MEW). The use of pHMGCL with MEW vastly improves the cellular response to the mechanical anisotropy. Cardiac progenitor cells (CPCs) are able to align more efficiently along the preferential direction of the melt electrospun pHMGCL fiber scaffolds in comparison to electrospun poly(ε-caprolactone)-based scaffolds. Overall, this study describes for the first time that highly ordered microfiber (4.0-7.0 µm) scaffolds based on pHMGCL can be reproducibly generated with MEW and that these scaffolds can support and guide the growth of CPCs and thereby potentially enhance their therapeutic potential.

Indexed as

Biocompatible MaterialsCaproatesHeartLactonesMicroscopy, Electron, ScanningPolyestersPolymersPorosityTissue EngineeringTissue ScaffoldsBiocompatible MaterialsCaproatescaprolactoneLactonespolycaprolactonePolyestersPolymerscardiac tissue engineeringcell orientationfunctional scaffoldsmelt electrospinning writingpolymer processing

Identifiers

PMID28699224
PMCPMC7116102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.